162
Views
7
CrossRef citations to date
0
Altmetric
Clinical Focus: Clinical Immunology & Infectious Diseases - Original Research

Increased plasma/serum levels of prolactin in multiple sclerosis: a meta-analysis

, , &
Pages 605-610 | Received 06 Nov 2016, Accepted 11 Jan 2017, Published online: 25 Jan 2017

References

  • Weiner HL. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol. 2004;61:1613–1615.
  • Boissy AR, Cohen JA. Multiple sclerosis symptom management. Expert Rev Neurother. 2007;7:1213–1222.
  • Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010;9:520–532.
  • Grattan DR, Kokay IC. Prolactin: a pleiotropic neuroendocrine hormone. J Neuroendocrinol. 2008;20:752–763.
  • Ben-Jonathan N, Mershon JL, Allen DL, et al. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev. 1996;17:639–669.
  • Freeman ME, Kanyicska B, Lerant A, et al. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80:1523–1631.
  • Yong VW. Prospects of repair in multiple sclerosis. J Neurol Sci. 2009;277(Suppl 1):S16–S18.
  • Chikanza IC. Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann NY Acad Sci. 1999;876:119–130.
  • Grinsted L, Heltberg A, Hagen C, et al. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Intern Med. 1989;226:241–244.
  • Kira J, Harada M, Yamaguchi Y, et al. Hyperprolactinemia in multiple sclerosis. J Neurol Sci. 1991;102:61–66.
  • Yamasaki K, Horiuchi I, Minohara M, et al. Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med. 2000;39:296–299.
  • Harirchian MH, Sahraian MA, Shirani A. Serum prolactin level in patients with multiple sclerosis: a case control study. Med Sci Monit. 2006;12:CR177–CR180.
  • Heesen C, Gold SM, Bruhn M, et al. Prolactin stimulation in multiple sclerosis–an indicator of disease subtypes and activity? Endocr Res. 2002;28:9–18.
  • Nakken B, Szodoray P. Accelerated atherosclerosis in rheumatoid arthritis: rationale for mannose-binding lectins? J Rheumatol. 2010;37:482–484.
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
  • Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
  • Moshirzadeh S, Ghareghozli K, Harandi AA, et al. Serum prolactin level in patients with relapsing-remitting multiple sclerosis during relapse. J Clin Neurosci Title. 2012;19:622–623.
  • Markianos M, Koutsis G, Evangelopoulos ME, et al. Serum and cerebrospinal fluid prolactin levels in male and female patients with clinically-isolated syndrome or relapsing-remitting multiple sclerosis. J Neuroendocrinol. 2010;22:503–508.
  • Nabavi SM, Koupai SA, Nejati MR, et al. Menstrual irregularities and related plasma hormone levels in multiple sclerosis patients treated with beta interferone. Acta Med Iran. 2008;48:36–41.
  • Heesen C, Schulz H, Schmidt M, et al. Endocrine and cytokine responses to acute psychological stress in multiple sclerosis. Brain Behav Immun. 2002;16:282–287.
  • Azar ST, Yamout B. Prolactin secretion is increased in patients with multiple sclerosis. Endocr Res. 1999;25:207–214.
  • Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005;58:840–846.
  • Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev. 1996;17:64–102.
  • Orbach H, Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev. 2007;6:537–542.
  • Riskind PN, Massacesi L, Doolittle TH, et al. The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol. 1991;29:542–547.
  • Wei T, Lightman SL. The neuroendocrine axis in patients with multiple sclerosis. Brain. 1997;120(Pt 6):1067–1076.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.